Kyorin Holdings Inc banner

Kyorin Holdings Inc
TSE:4569

Watchlist Manager
Kyorin Holdings Inc Logo
Kyorin Holdings Inc
TSE:4569
Watchlist
Price: 1 660 JPY -0.3%
Market Cap: ¥95.4B

Kyorin Holdings Inc
EPS (Diluted)

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Kyorin Holdings Inc
EPS (Diluted) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company EPS (Diluted) CAGR 3Y CAGR 5Y CAGR 10Y
Kyorin Holdings Inc
TSE:4569
EPS (Diluted)
¥187
CAGR 3-Years
23%
CAGR 5-Years
11%
CAGR 10-Years
0%
Takeda Pharmaceutical Co Ltd
TSE:4502
EPS (Diluted)
¥71
CAGR 3-Years
-26%
CAGR 5-Years
-9%
CAGR 10-Years
N/A
Daiichi Sankyo Co Ltd
TSE:4568
EPS (Diluted)
¥164
CAGR 3-Years
75%
CAGR 5-Years
35%
CAGR 10-Years
-10%
Otsuka Holdings Co Ltd
TSE:4578
EPS (Diluted)
¥687
CAGR 3-Years
41%
CAGR 5-Years
20%
CAGR 10-Years
14%
Chugai Pharmaceutical Co Ltd
TSE:4519
EPS (Diluted)
¥263
CAGR 3-Years
5%
CAGR 5-Years
15%
CAGR 10-Years
22%
Astellas Pharma Inc
TSE:4503
EPS (Diluted)
¥180
CAGR 3-Years
34%
CAGR 5-Years
19%
CAGR 10-Years
8%
No Stocks Found

Kyorin Holdings Inc
Glance View

Market Cap
95.4B JPY
Industry
Pharmaceuticals

KYORIN Holdings, Inc. engages in the development, manufacture and sale of pharmaceutical products through its subsidiaries. The company is headquartered in Chiyoda-Ku, Tokyo-To and currently employs 2,243 full-time employees. The company went IPO on 2006-03-10. The firm operates through two business segments. The Pharmaceuticals segment is engaged in the manufacture, purchase and sales of pharmaceutical products, the evaluation of technologies, the inspection, analysis and negotiation of license affiliations, as well as the research of new drugs and candidate compounds. The company also engages in the purchase and sales of medical promotion tools and packaging materials. The Healthcare segment is engaged in the manufacturing, sales and purchase of environmental sanitation products, general purpose medicines and skin care products.

Intrinsic Value
2 094.79 JPY
Undervaluation 21%
Intrinsic Value
Price

See Also

What is Kyorin Holdings Inc's EPS (Diluted)?
EPS (Diluted)
187.4 JPY

Based on the financial report for Dec 31, 2025, Kyorin Holdings Inc's EPS (Diluted) amounts to 187.4 JPY.

What is Kyorin Holdings Inc's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
0%

Over the last year, the EPS (Diluted) growth was 180%. The average annual EPS (Diluted) growth rates for Kyorin Holdings Inc have been 23% over the past three years , 11% over the past five years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett